NASDAQ Composite opens in less than ten hours and Arena Pharmaceuticals’s pre-market value is already 1.78% up.
The last session, NASDAQ Composite finished with Arena Pharmaceuticals rising 2.87% to $80.56. NASDAQ Composite fell 0.12% to $13,112.64, following last session’s downward trend on what was a somewhat negative trend exchanging session.
Arena Pharmaceuticals’s last close was $78.31, 11.95% below its 52-week high of $90.19.
Arena Pharmaceuticals’s Sales
Arena Pharmaceuticals’s sales growth is a negative 81.3% for the current quarter and 155.7% for the next. The company’s growth estimates for the ongoing quarter is a negative 4.5% and positive 4.5% for the next.
Arena Pharmaceuticals’s last day, last week, and last month’s average volatility was 1.71%, 0.48%, and 0.59%, respectively.
Arena Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 7.15%, 4.71%, and 3.72%, respectively.